V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003009 | 280002275 | 1.69 | 111.5 | null | 2017-02-19 | 2017-03-03 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | 280024815 | CISPLATIN + FLUOROURACIL |
| 280003010 | 280002276 | 1.73 | 53 | Palliative (P) | 2013-04-12 | 2013-04-30 | DOXORUBICIN + IFOSFAMIDE | null | N | 280024816 | DOXORUBICIN + IFOSFAMIDE |
| 280003011 | 280002277 | null | null | Neo-adjuvant (N) | 2014-12-24 | 2015-01-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024817 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003012 | 280002278 | 1.82 | 73.6 | Curative (C) | 2016-12-14 | 2016-12-25 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280024821 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003013 | 280002279 | null | null | Neo-adjuvant (N) | 2015-12-04 | 2015-12-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024823 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003014 | 280002280 | 1.8 | 57 | Neo-adjuvant (N) | 2017-08-04 | 2017-08-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280024825 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003015 | 280002281 | 1.72 | 57 | Neo-adjuvant (N) | 2015-05-12 | 2015-06-01 | Cisplatin +Fluorouracil (3 wk) | N | N | 280024828 | CISPLATIN + FLUOROURACIL |
| 280003016 | 280007220 | 1.8 | 90 | Curative (C) | 2017-09-11 | 2017-09-11 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280024830 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003017 | 280002282 | 1.61 | 52.3 | Neo-adjuvant (N) | 2015-10-02 | 2015-10-06 | DOXORUBICIN + IFOSFAMIDE | 2 | null | 280024831 | DOXORUBICIN + IFOSFAMIDE |
| 280003018 | 280002283 | 1.69 | 47 | Adjuvant (A) | 2014-03-04 | 2014-03-05 | Doxorubicin + Ifosfamide | N | N | 280024833 | DOXORUBICIN + IFOSFAMIDE |
| 280003019 | 280002283 | 1.83 | 119.3 | Neo-adjuvant (N) | 2018-01-24 | 2018-01-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280024833 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003020 | 280002284 | 1.78 | 56.3 | Palliative (P) | 2017-11-27 | 2017-11-27 | Doxorubicin + Ifosfamide | 02 | N | 280024842 | DOXORUBICIN + IFOSFAMIDE |
| 280003021 | 280002285 | 1.76 | 89.1 | Neo-adjuvant (N) | 2014-08-18 | 2014-08-18 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280024844 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003022 | 280002286 | 1.59 | 104 | Curative (C) | 2015-09-16 | 2015-10-21 | CETUXIMAB + RT | N | Y | 280024848 | CETUXIMAB + RT |
| 280003023 | 280007222 | 1.69 | 63 | Curative (C) | 2015-06-12 | 2015-06-25 | CETUXIMAB + RT | N | Y | 280024849 | CETUXIMAB + RT |
| 280003024 | 280007222 | 1.88 | 46 | Curative (C) | 2015-11-01 | 2015-11-22 | Cetuximab + Radiotherapy Load | N | N | 280024849 | CETUXIMAB + RT |
| 280003025 | 280007222 | 1.85 | 50.2 | Adjuvant (A) | 2018-04-28 | 2018-05-14 | Doxorubicin + Ifosfamide | N | N | 280024849 | DOXORUBICIN + IFOSFAMIDE |
| 280003026 | 280002287 | 1.55 | 88.3 | Neo-adjuvant (N) | 2014-04-10 | 2014-04-10 | CISPLATIN + FLUOROURACIL | 02 | N | 280024853 | CISPLATIN + FLUOROURACIL |
| 280003027 | 280002288 | null | null | Palliative (P) | null | 2016-07-19 | Doxorubicin + Ifosfamide | null | null | 280024854 | DOXORUBICIN + IFOSFAMIDE |
| 280003028 | 280007223 | 1.5 | 53.3 | Neo-adjuvant (N) | 2013-04-16 | 2013-04-20 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024855 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003029 | 280007223 | 1.7 | 65.6 | Neo-adjuvant (N) | 2015-08-15 | 2015-09-11 | Doxorubicin + Ifosfamide | 2 | N | 280024855 | DOXORUBICIN + IFOSFAMIDE |
| 280003030 | 280002289 | 1.64 | 106 | Neo-adjuvant (N) | 2016-05-21 | 2016-05-31 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280024859 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003031 | 280002290 | 1.73 | 94 | Neo-adjuvant (N) | 2015-09-01 | 2015-09-19 | DOXORUBICIN + IFOSFAMIDE | N | N | 280024860 | DOXORUBICIN + IFOSFAMIDE |
| 280003032 | 280002291 | null | 59.2 | Disease modification (D) | 2018-09-29 | 2018-12-09 | Doxorubicin + Ifosfamide | N | N | 280024861 | DOXORUBICIN + IFOSFAMIDE |
| 280003033 | 280002292 | 1.73 | 77.5 | Palliative (P) | 2013-03-23 | 2013-04-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280024862 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003034 | 280002293 | 1.7 | 63 | Curative (C) | 2013-05-03 | 2013-06-14 | CETUXIMAB + RT | 02 | N | 280024865 | CETUXIMAB + RT |
| 280003035 | 280002294 | 1.59 | 80.5 | Neo-adjuvant (N) | 2015-12-07 | 2015-12-08 | Cisplatin +Fluorouracil (3 wk) | N | N | 280024866 | CISPLATIN + FLUOROURACIL |
| 280003036 | 280002295 | 1.53 | 63.5 | Neo-adjuvant (N) | 2016-12-17 | 2016-12-19 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 280024867 | DOXORUBICIN + IFOSFAMIDE |
| 280003037 | 280002295 | 1.72 | 70 | Curative (C) | 2016-10-23 | 2016-11-03 | Cetuximab + Radiotherapy Maint | N | Y | 280024867 | CETUXIMAB + RT |
| 280003038 | 280002295 | null | 142 | Palliative (P) | null | 2016-01-09 | Doxorubicin + Ifosfamide | null | null | 280024867 | DOXORUBICIN + IFOSFAMIDE |
| 280003039 | 280002296 | null | null | null | 2013-07-31 | 2013-07-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280024870 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003040 | 280002297 | 1.7 | 93 | Neo-adjuvant (N) | 2016-08-14 | 2016-08-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280024874 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003041 | 280002298 | 1.69 | 128 | Neo-adjuvant (N) | 2017-11-15 | 2017-11-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280024875 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003042 | 280002299 | 1.68 | 67.5 | Curative (C) | null | 2013-04-16 | CETUXIMAB + RT | N | Y | 280024876 | CETUXIMAB + RT |
| 280003043 | 280002300 | 1.77 | 89.1 | Curative (C) | 2009-06-26 | 2013-07-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024877 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003044 | 280002301 | 1.79 | 94 | Neo-adjuvant (N) | 2017-11-15 | 2017-11-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280024882 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003045 | 280002302 | 1.67 | 59 | null | null | 2014-11-18 | Cisplatin +Fluorouracil (3 wk) | null | null | 280024884 | CISPLATIN + FLUOROURACIL |
| 280003046 | 280002303 | 0.9 | 68.3 | Curative (C) | 2014-03-04 | 2014-03-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024885 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003047 | 280002304 | null | 60 | Curative (C) | null | 2016-12-27 | CETUXIMAB + RT | null | Y | 280024886 | CETUXIMAB + RT |
| 280003048 | 280002304 | 1.61 | 75 | Adjuvant (A) | 2018-02-08 | 2018-02-21 | Doxorubicin + Ifosfamide | 02 | null | 280024886 | DOXORUBICIN + IFOSFAMIDE |
| 280003049 | 280002304 | null | null | Neo-adjuvant (N) | 2017-07-25 | 2017-07-25 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280024886 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003050 | 280002305 | 1.75 | 73.7 | Curative (C) | 2016-01-05 | 2016-01-31 | CETUXIMAB + RT | N | Y | 280024891 | CETUXIMAB + RT |
| 280003051 | 280002306 | 1.75 | 70 | Neo-adjuvant (N) | 2015-05-08 | 2015-05-20 | Cisplatin +Fluorouracil (3 wk) | 01 | null | 280024894 | CISPLATIN + FLUOROURACIL |
| 280003052 | 280002307 | 1.67 | null | Neo-adjuvant (N) | 2016-08-15 | 2016-09-07 | Doxorubicin + Ifosfamide | 02 | N | 280024895 | DOXORUBICIN + IFOSFAMIDE |
| 280003053 | 280002308 | 1.6 | 85.1 | null | 2017-09-07 | 2017-09-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024896 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003054 | 280002309 | 1.78 | 57 | Adjuvant (A) | 2014-04-30 | 2014-05-15 | Cetuximab + Radiotherapy Load | 02 | Y | 280024897 | CETUXIMAB + RT |
| 280003055 | 280002310 | 1.73 | 81.2 | Curative (C) | 2016-01-27 | 2016-02-12 | Cetuximab + Radiotherapy Load | null | Y | 280024899 | CETUXIMAB + RT |
| 280003056 | 280002311 | 1.61 | 67.7 | Curative (C) | 2017-01-31 | 2017-02-09 | Cetuximab + Radiotherapy Load | N | N | 280024900 | CETUXIMAB + RT |
| 280003057 | 280002312 | 1.78 | 99.6 | null | 2017-06-14 | 2017-07-04 | Doxorubicin + Ifosfamide | N | N | 280024901 | DOXORUBICIN + IFOSFAMIDE |
| 280003058 | 280002313 | null | null | Curative (C) | 2018-06-08 | 2018-06-16 | DOXORUBICIN + IFOSFAMIDE | N | N | 280024902 | DOXORUBICIN + IFOSFAMIDE |